Literature DB >> 17996795

Hepatic precancerous lesions and small hepatocellular carcinoma.

Prodromos Hytiroglou1, Young Nyun Park, Glenn Krinsky, Neil D Theise.   

Abstract

Precancerous lesions that may be detected in chronically diseased, usually cirrhotic livers, include: clusters of hepatocytes with atypia and increased proliferative rate (dysplastic foci) that usually represent an incidental finding in biopsy or resection specimens; and grossly evident lesions (dysplastic nodules) that may be detected on radiologic examination. There are two types of small hepatocellular carcinoma (HCC) (defined as HCC that measures less than 2 cm): early HCC, which is well-differentiated and has indistinct margins; and distinctly nodular small HCC, which is well- or moderately differentiated, and is usually surrounded by a fibrous capsule. Precise diagnosis of precancerous and early cancerous lesions by imaging methods is often difficult or impossible. Detection of a dysplastic lesion in a biopsy specimen is a marker of increased risk for HCC development, and warrants increased surveillance. High-grade dysplastic nodules and small HCCs should be treated by local ablation, surgical resection, or liver transplantation.

Entities:  

Mesh:

Year:  2007        PMID: 17996795     DOI: 10.1016/j.gtc.2007.08.010

Source DB:  PubMed          Journal:  Gastroenterol Clin North Am        ISSN: 0889-8553            Impact factor:   3.806


  31 in total

1.  Identification of liver cancer progenitors whose malignant progression depends on autocrine IL-6 signaling.

Authors:  Guobin He; Debanjan Dhar; Hayato Nakagawa; Joan Font-Burgada; Hisanobu Ogata; Yuhong Jiang; Shabnam Shalapour; Ekihiro Seki; Shawn E Yost; Kristen Jepsen; Kelly A Frazer; Olivier Harismendy; Maria Hatziapostolou; Dimitrios Iliopoulos; Atsushi Suetsugu; Robert M Hoffman; Ryosuke Tateishi; Kazuhiko Koike; Michael Karin
Journal:  Cell       Date:  2013-10-10       Impact factor: 41.582

Review 2.  Apoptosis in liver carcinogenesis and chemotherapy.

Authors:  Joaquim Moreno-Càceres; Isabel Fabregat
Journal:  Hepat Oncol       Date:  2015-11-11

3.  Keratin 19 epithelial patterns in cirrhotic stroma parallel hepatocarcinogenesis.

Authors:  Jochen K M Lennerz; William C Chapman; Elizabeth M Brunt
Journal:  Am J Pathol       Date:  2011-06-23       Impact factor: 4.307

4.  Histologic characteristics of hepatocellular carcinomas showing atypical enhancement patterns on 4-phase MDCT examination.

Authors:  Injoong Kim; Myeong-Jin Kim
Journal:  Korean J Radiol       Date:  2012-08-28       Impact factor: 3.500

5.  Differentiation between dysplastic nodule and early-stage hepatocellular carcinoma: the utility of conventional MR imaging.

Authors:  Chen-Te Chou; Jung-Mao Chou; Ting-An Chang; Shiu-Feng Huang; Chia-Bang Chen; Yao-Li Chen; Ran-Chou Chen
Journal:  World J Gastroenterol       Date:  2013-11-14       Impact factor: 5.742

6.  Progression of diethylnitrosamine-induced hepatic carcinogenesis in carnitine-depleted rats.

Authors:  Salim S Al-Rejaie; Abdulaziz M Aleisa; Abdulaziz A Al-Yahya; Saleh A Bakheet; Abdulmalik Alsheikh; Amal G Fatani; Othman A Al-Shabanah; Mohamed M Sayed-Ahmed
Journal:  World J Gastroenterol       Date:  2009-03-21       Impact factor: 5.742

Review 7.  The epidemiology of hepatocellular cancer: from the perspectives of public health problem to tumor biology.

Authors:  Stephen Caldwell; Sang H Park
Journal:  J Gastroenterol       Date:  2009-01-16       Impact factor: 7.527

Review 8.  Multistep human hepatocarcinogenesis: correlation of imaging with pathology.

Authors:  Masatoshi Kudo
Journal:  J Gastroenterol       Date:  2009-01-16       Impact factor: 7.527

9.  Hepatitis C-associated hepatocellular carcinomas in non-cirrhotic livers.

Authors:  Matthew M Yeh; Hubert Darius-J Daniel; Michael Torbenson
Journal:  Mod Pathol       Date:  2009-11-20       Impact factor: 7.842

Review 10.  Liver carcinogenesis: from naughty chemicals to soothing fat and the surprising role of NRF2.

Authors:  Michael Karin; Debanjan Dhar
Journal:  Carcinogenesis       Date:  2016-05-04       Impact factor: 4.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.